Skip to content

Clinical trials

Carcinoma, Renal Cell trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Country / region: Italy Clear all

149 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20033
20042
20053
20064
20071
20088
20094
20105
20114
20126
20131
20145
20154
201613
201711
20188
201913
20206
202113
20225
20237
20244
20257
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed74
Recruiting24
Terminated19
Active, not recruiting18
Unknown status9
Not yet recruiting3
Approved for marketing1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals17
Bristol-Myers Squibb10
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano9
Merck Sharp & Dohme LLC9
Pfizer9
Hoffmann-La Roche8
Bayer5
Exelixis5
IRCCS San Raffaele4
Incyte Corporation4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell149
Kidney Neoplasms23
Carcinoma, Non-Small-Cell Lung21
Melanoma17
Neoplasm Metastasis14
Neoplasms14
Colorectal Neoplasms12
Squamous Cell Carcinoma of Head and Neck9
Triple Negative Breast Neoplasms8
Carcinoma7

Trials

Showing 1 to 25 of 149. Each trial links to its page on Pharma Observatory.

49 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.